Verition Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
+14,169
| New | +$1.61M | 0.01% | 1569 |
|
|
2025
Q1 | – | Sell |
-5,876
| Closed | -$630K | – | 2788 |
|
|
2024
Q4 | $630K | Sell |
5,876
-85
| -1% | -$9.11K | ﹤0.01% | 1753 |
|
|
2024
Q3 | $597K | Buy |
+5,961
| New | +$597K | ﹤0.01% | 1598 |
|
|
2023
Q4 | – | Sell |
-5,321
| Closed | -$319K | – | 2074 |
|
|
2023
Q3 | $319K | Buy |
+5,321
| New | +$319K | ﹤0.01% | 1392 |
|
|
2019
Q1 | – | Sell |
-3,184
| Closed | -$270K | – | 1144 |
|
|
2018
Q4 | $270K | Buy |
+3,184
| New | +$270K | 0.02% | 595 |
|